Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

16.60
Delayed Data
As of 4:00pm ET
 +0.10 / +0.61%
Today’s Change
9.05
Today|||52-Week Range
24.00
+11.41%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close16.50
Today’s open16.25
Day’s range16.05 - 16.80
Volume148,872
Average volume (3 months)206,388
Market cap$587.9M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)-9.51%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.81

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.31-1.96%
SCLNSciClone Pharmaceuti...+0.05+0.45%
OTICOtonomy Inc-0.10-0.53%
ALDRAlder Biopharmaceuti...-0.15-1.68%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.01
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Operating &
Financial Officer
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts